Sign in

CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
520845822
Phone
352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 8-K Event Regulation FD disclosure
  2. 4 Other acquisition Director acquired 9,503 shares (other)
  3. 4 Other acquisition Director acquired 9,503 shares (other)
  4. 4 Grant or award CFO acquired 5,208 shares (grant or award)
  5. 4 Grant or award Dir Govt Relations/Sectry acquired 9,115 shares (grant or award)
  6. 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 19,531 shares (grant or award)
  7. 4 Other acquisition Director acquired 8,264 shares (other)
  8. 4 Other acquisition Director acquired 8,264 shares (other)
  9. 4 Grant or award CFO acquired 4,433 shares (grant or award)
  10. 4 Grant or award Dir Govt Relations/Sectry acquired 7,752 shares (grant or award)
  11. 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 16,622 shares (grant or award)
  12. 10-Q Report Quarterly Report
  13. 4 Other acquisition Director acquired 7,603 shares (other)
  14. 4 Other acquisition Director acquired 7,603 shares (other)
  15. 4 Grant or award CFO acquired 4,167 shares (grant or award)
  16. 4 Grant or award Dir Govt Relations/Sectry acquired 7,297 shares (grant or award)
  17. 4 Grant or award Exec. Vice Chairman/CEO/Pres. acquired 15,625 shares (grant or award)
  18. 4 Other acquisition Director acquired 6,911 shares (other)
  19. 4 Other acquisition Director acquired 6,911 shares (other)
  20. 4 Grant or award Dir Govt Relations/Sectry acquired 6,286 shares (grant or award)

Page 26 of 82 · 1,637 filings